Thanks Ronnie,
Thanks for your imput
I do happen to know a little about this company and some of the people associated with it
What Im trying to evaluate is the risk reward scenario associated with the outcome of the March 22 meeting
I respect your valuation of $1.50+, as you have a good knowledge of the product, but does anyone else besides wilson htm cover this stock and give a valuation?
I also agree that the the odds of approval are good, but what do I stand to lose if they are knocked back? In other words if they go to $1.50 on approval but go back to say $0.55 on rejection, then this to me is a very attractive risk to take. Its this range of risk Im trying to get a handle on
- Forums
- ASX - By Stock
- CXS
- latest wilsonhtm report
latest wilsonhtm report, page-4
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug